Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30